Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2022		144,755,000
Beginning balance at Apr. 30, 2022	$ 334,163	$ 7	$ 424,562	$ 23	$ (90,429)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		589,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	1,977		1,977
Share-based compensation	5,546		5,546
Warrant contra revenue	388		388
Total comprehensive loss	(169)			(96)	(73)
Ending balance (in shares) at Jul. 30, 2022		145,344,000
Ending balance at Jul. 30, 2022	341,905	$ 7	432,473	(73)	(90,502)
Beginning balance (in shares) at Apr. 30, 2022		144,755,000
Beginning balance at Apr. 30, 2022	334,163	$ 7	424,562	23	(90,429)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive loss	(702)
Ending balance (in shares) at Jan. 28, 2023		147,430,000
Ending balance at Jan. 28, 2023	354,553	$ 7	445,654	(69)	(91,039)
Beginning balance (in shares) at Jul. 30, 2022		145,344,000
Beginning balance at Jul. 30, 2022	341,905	$ 7	432,473	(73)	(90,502)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		1,142,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	741		741
Share-based compensation	4,891		4,891
Warrant contra revenue	247		247
Total comprehensive loss	(3,680)			(320)	(3,360)
Ending balance (in shares) at Oct. 29, 2022		146,486,000
Ending balance at Oct. 29, 2022	344,104	$ 7	438,352	(393)	(93,862)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		944,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	1,873		1,873
Share-based compensation	5,169		5,169
Warrant contra revenue	260		260
Total comprehensive loss	3,147			324	2,823
Ending balance (in shares) at Jan. 28, 2023		147,430,000
Ending balance at Jan. 28, 2023	$ 354,553	$ 7	445,654	(69)	(91,039)
Beginning balance (in shares) at Apr. 29, 2023	148,651,000	148,651,000
Beginning balance at Apr. 29, 2023	$ 347,635	$ 7	454,795	(191)	(106,976)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		1,203,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	3,260		3,260
Share-based compensation	7,968		7,968
Warrant contra revenue	436		436
Total comprehensive loss	(11,859)			(162)	(11,697)
Ending balance (in shares) at Jul. 29, 2023		149,854,000
Ending balance at Jul. 29, 2023	$ 347,440	$ 7	466,459	(353)	(118,673)
Beginning balance (in shares) at Apr. 29, 2023	148,651,000	148,651,000
Beginning balance at Apr. 29, 2023	$ 347,635	$ 7	454,795	(191)	(106,976)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total comprehensive loss	$ (18,036)
Ending balance (in shares) at Jan. 27, 2024	163,068,000	163,068,000
Ending balance at Jan. 27, 2024	$ 533,967	$ 8	659,162	(335)	(124,868)
Beginning balance (in shares) at Jul. 29, 2023		149,854,000
Beginning balance at Jul. 29, 2023	347,440	$ 7	466,459	(353)	(118,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		692,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	456	$ 1	455
Share-based compensation	8,144		8,144
Warrant contra revenue	354		354
Total comprehensive loss	(6,846)			(223)	(6,623)
Ending balance (in shares) at Oct. 28, 2023		150,546,000
Ending balance at Oct. 28, 2023	349,548	$ 8	475,412	(576)	(125,296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ordinary shares issued under equity incentive plans, net of RSU settlement (in shares)		2,082,000
Ordinary shares issued under equity incentive plans, net of tax withholding related to vesting of RSUs	970		970
Share-based compensation	8,332		8,332
Warrant contra revenue	1,033		1,033
Total comprehensive loss	669			241	428
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)		10,440,000
Issuance of ordinary share in connection with public offering, net of underwriter discounts and offering costs	$ 173,415		173,415
Ending balance (in shares) at Jan. 27, 2024	163,068,000	163,068,000
Ending balance at Jan. 27, 2024	$ 533,967	$ 8	$ 659,162	$ (335)	$ (124,868)